Annual Cash & Cash Equivalents
$58.21 M
+$32.65 M+127.72%
December 1, 2024
Summary
- As of March 15, 2025, FULC annual cash & cash equivalents is $58.21 million, with the most recent change of +$32.65 million (+127.72%) on December 1, 2024.
- During the last 3 years, FULC annual cash & cash equivalents has risen by +$22.80 million (+64.38%).
- FULC annual cash & cash equivalents is now -39.81% below its all-time high of $96.71 million, reached on December 31, 2019.
Performance
FULC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$58.21 M
-$14.42 M-19.85%
December 31, 2024
Summary
- As of March 15, 2025, FULC quarterly cash and cash equivalents is $58.21 million, with the most recent change of -$14.42 million (-19.85%) on December 31, 2024.
- Over the past year, FULC quarterly cash and cash equivalents has increased by +$32.65 million (+127.72%).
- FULC quarterly cash and cash equivalents is now -42.70% below its all-time high of $101.60 million, reached on September 30, 2019.
Performance
FULC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FULC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +127.7% | +127.7% |
| 3 y3 years | +64.4% | +127.7% |
| 5 y5 years | -39.8% | +127.7% |
FULC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +127.7% | -36.0% | +127.7% |
| 5 y | 5-year | -39.8% | +127.7% | -42.2% | +129.4% |
| alltime | all time | -39.8% | >+9999.0% | -42.7% | +129.4% |
Fulcrum Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $58.21 M(-19.9%) |
| Dec 2024 | $58.21 M(+127.7%) | - |
| Sep 2024 | - | $72.63 M(-16.2%) |
| Jun 2024 | - | $86.70 M(+117.0%) |
| Mar 2024 | - | $39.95 M(+56.3%) |
| Dec 2023 | $25.56 M(-27.2%) | $25.56 M(-15.0%) |
| Sep 2023 | - | $30.08 M(-11.4%) |
| Jun 2023 | - | $33.97 M(-2.2%) |
| Mar 2023 | - | $34.73 M(-1.0%) |
| Dec 2022 | $35.10 M(-0.9%) | $35.10 M(-61.4%) |
| Sep 2022 | - | $90.94 M(+126.5%) |
| Jun 2022 | - | $40.15 M(+20.5%) |
| Mar 2022 | - | $33.31 M(-5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $35.41 M(-37.9%) | $35.41 M(-45.9%) |
| Sep 2021 | - | $65.47 M(+15.3%) |
| Jun 2021 | - | $56.78 M(-43.6%) |
| Mar 2021 | - | $100.75 M(+76.6%) |
| Dec 2020 | $57.05 M(-41.0%) | $57.05 M(-33.1%) |
| Sep 2020 | - | $85.22 M(+12.6%) |
| Jun 2020 | - | $75.72 M(+198.3%) |
| Mar 2020 | - | $25.38 M(-73.8%) |
| Dec 2019 | $96.71 M(+32.9%) | $96.71 M(-4.8%) |
| Sep 2019 | - | $101.60 M(+104.7%) |
| Jun 2019 | - | $49.63 M(-20.5%) |
| Mar 2019 | - | $62.45 M(-14.2%) |
| Dec 2018 | $72.80 M(>+9900.0%) | $72.80 M |
| Dec 2017 | $407.00 K | - |
FAQ
- What is Fulcrum Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual cash & cash equivalents year-on-year change?
- What is Fulcrum Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Fulcrum Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of FULC is $58.21 M
What is the all time high annual cash & cash equivalents for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual cash & cash equivalents is $96.71 M
What is Fulcrum Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, FULC annual cash & cash equivalents has changed by +$32.65 M (+127.72%)
What is Fulcrum Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FULC is $58.21 M
What is the all time high quarterly cash and cash equivalents for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly cash and cash equivalents is $101.60 M
What is Fulcrum Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, FULC quarterly cash and cash equivalents has changed by +$32.65 M (+127.72%)